Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyoichi Kaira

Showing results (1-10 of 467) with videos related to

Pageof 47
Sort By:
Internal Medicine (Tokyo, Japan)|November 9, 2022
Dilemma Concerning the Differential Diagnosis of Hematological Malignancy and Bone Metastasis Arising from Lung CancerKyoichi Kaira
Cancer Chemotherapy and Pharmacology|June 26, 2018
Reply to: Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinomaKyoichi Kaira
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|November 4, 2009
[A case of non-tuberculosis mycobacterium and lung cancer showing solitary nodular shadow]Kyoichi Kaira
Onkologie|February 8, 2012
Erlotinib after failure of gefitinib treatment of more than 6 months in advanced non-small cell lung cancerKyoichi Kaira, Nobuyuki Yamamoto
Expert Opinion on Medical Diagnostics|March 19, 2013
Prognostic and predictive factors in resected non-small-cell lung cancerKyoichi Kaira, Nobuyuki Yamamoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Adverse effects of antimetabolite fluoropyrimidine analog]Takayuki Asao, Kyoichi Kaira
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Hand-foot syndrome]Takayuki Asao, Kyoichi Kaira
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Epiregulin as a therapeutic target in non-small-cell lung cancerNoriaki Sunaga, Kyoichi Kaira
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2006
Right thoracic stomach resulting from hiatal herniaKyoichi Kaira, Masatomo Mori
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 25, 2019
Drastic Response of Re-challenge of EGFR-TKIs Immediately After Nivolumab Therapy in EGFR-TKI-Resistant PatientsKyoichi Kaira, Hiroshi Kagamu
Pageof 47

Showing results (1-10 of 467) with videos related to

Sort By:
Pageof 47
Internal Medicine (Tokyo, Japan)|November 9, 2022
Dilemma Concerning the Differential Diagnosis of Hematological Malignancy and Bone Metastasis Arising from Lung CancerKyoichi Kaira
Cancer Chemotherapy and Pharmacology|June 26, 2018
Reply to: Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinomaKyoichi Kaira
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|November 4, 2009
[A case of non-tuberculosis mycobacterium and lung cancer showing solitary nodular shadow]Kyoichi Kaira
Onkologie|February 8, 2012
Erlotinib after failure of gefitinib treatment of more than 6 months in advanced non-small cell lung cancerKyoichi Kaira, Nobuyuki Yamamoto
Expert Opinion on Medical Diagnostics|March 19, 2013
Prognostic and predictive factors in resected non-small-cell lung cancerKyoichi Kaira, Nobuyuki Yamamoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Adverse effects of antimetabolite fluoropyrimidine analog]Takayuki Asao, Kyoichi Kaira
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Hand-foot syndrome]Takayuki Asao, Kyoichi Kaira
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Epiregulin as a therapeutic target in non-small-cell lung cancerNoriaki Sunaga, Kyoichi Kaira
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2006
Right thoracic stomach resulting from hiatal herniaKyoichi Kaira, Masatomo Mori
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 25, 2019
Drastic Response of Re-challenge of EGFR-TKIs Immediately After Nivolumab Therapy in EGFR-TKI-Resistant PatientsKyoichi Kaira, Hiroshi Kagamu
Pageof 47